Dr. Usman
Latest Articles by Dr. Usman
Biopeptide EL: Molecular Characterization, Elastin-Binding Receptor Dermatology, and Extracellular Matrix Research
Biopeptide EL is the commercial designation for a synthetic lipopeptide formally classified under the INCI as Palmitoyl Hexapeptide-12. Biopeptide EL is composed of a hexapeptide sequence...
BPC157: Molecular Characterization, Pleiotropic Signaling Mechanisms, and Preclinical Research
Body Protection Compound-157 (BPC157) is a synthetic pentadecapeptide composed of 15 amino acids. It is derived from a partial sequence of a gastric protective protein identified in gastric...
Copper Peptides: Molecular Characterization, Mechanistic Biology, and Emerging Research
Copper peptides are a class of naturally occurring and synthetically reproduced small peptide and copper ion complexes in which Cu²⁺ coordinates with specific amino acid sequences to form stable...
Modified GRF 1-29 and GHRP-2 Peptide Blend: Receptor Pharmacology, Somatotroph Signaling, and Neuroendocrine Research
The Modified GRF 1-29 and GHRP-2 peptide blend is a dual-component research formulation combining a stabilized growth hormone-releasing hormone (GHRH) analog with a synthetic ghrelin-mimetic...
Fragment 176-191, Modified GRF 1-29, and Ipamorelin Blend: Adipose Metabolism, GH Axis Modulation, and Receptor Signaling Research
The Fragment 176-191, Modified GRF 1-29, and Ipamorelin peptide blend is a research-grade tri-component formulation combining three structurally and mechanistically distinct synthetic peptides....
PNC-27: Structural Characterization, HDM-2-Dependent Membrane Targeting, and Selective Tumor Cell Necrosis
PNC-27 is a synthetic chimeric peptide engineered to engage the double minute-2 protein (HDM-2; the broader mammalian homolog of murine MDM-2) expressed on the plasma membranes of cancer cells. The...
AOD-9604: Molecular Characterization, Lipolytic Mechanisms, and Emerging Research in Tissue Biology and Mammalian Oncology
AOD-9604 is a synthetic hexadecapeptide fragment derived from the C-terminal region of hGH. It corresponds to residues 176–191 of the 191-amino acid hGH polypeptide, with the addition of a tyrosine...
Tesamorelin, Modified GRF 1-29, and Ipamorelin Peptide Blend: Growth Hormone Axis Pharmacology and Preclinical Research
The Tesamorelin, Modified GRF 1-29, and Ipamorelin peptide blend is a research-grade formulation combining three structurally distinct synthetic peptides, each engaging the growth hormone (GH)...
Sermorelin, GHRP-6, and GHRP-2 Peptide Blend: Receptor Pharmacology, Intracellular Signaling, and Neuroendocrine Research
The Sermorelin & GHRP-6 & GHRP-2 peptide blend is a research-grade formulation designed to facilitate the study of integrated signaling within the somatotropin and ghrelin-related regulatory axes....
